Relais' Q1 results were well in line with LSEG Data and Analytics consensus expectations, while the ...
Getting ready for the OEM ramp-up Aircraft production + penetration to drive 10% AM growth 27-13x EB...
CEO Daniel Krook emphasised the increased growth focus for H1.
EcoRub (”EcoRub” eller ”bolaget”) publicerade den 12 maj 2025 bolagets delårsrapport för det första ...
Redeye met with Biovoca CEO Anders Rylander to discuss the collaboration with Tempus AI, which targe...
BIovica has entered a reference lab agreement with Tempus a US listed company.
Redeye has interviewed Pia Renaudin, CEO at Scibase, in connection with the Q1 report.
Q1 confirms that Moberg’s Terclara is the market leader in Sweden and that Terclara is on track for ...
Redeye comments on IRLAB’s announcement of extended U.
Redeye states CoinShares surpassed its EBITDA expectations by 14%, primarily due to the CSCM segment...
Redeye updates on Embracer ahead of Q4-results (due 22 May) where we expect a strong year-end perfor...
Redeye has updated its near-term estimates and valuation following the Q1 report.
Net sales were in line with our expectation for Q1, with adjusted EBITA as much as 8% (EUR 0.
Cedergrenska AB (”Cedergrenska” eller ”Koncernen”) presenterade den 12 maj 2025 preliminära siffror ...
Orders and sales below consensus in Q1, costs above Optimistic H2'25 guidance reiterated, we cut EBI...
